The biowarfare aspects of Q fever

Joshua D. Hartzell, Kerry Wilson, Larry I. Lutwick*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Scopus citations


The zoonotic bacterium Coxiella burnetii is considered a category B bioterrorism agent related to the organism's ease of manufacture, environmental stability, readiness of aerosol transmission over long distances and the ability for very small numbers of organisms to cause disease in human. This chapter will review the history of the agent in biological warfare experimentation including the US Military's Whitecoat Program and the clinical aspects of the infection in the biological warfare setting. As an example of a potential biowarfare agent, the general management of mass casualty settings in the face of an attack will be described and the chemoprophylaxis of Q fever and the use of a vaccine for humans for prevention will be discussed.

Original languageEnglish
Title of host publicationThe Encyclopedia of Bacteriology Research Developments
PublisherNova Science Publishers, Inc.
Number of pages10
ISBN (Electronic)9781536193169
ISBN (Print)9781536192407
StatePublished - 8 Apr 2021


  • Antimicrobials
  • Biowarfare
  • Clinical symptoms
  • Immune response
  • US military's whitecoat program


Dive into the research topics of 'The biowarfare aspects of Q fever'. Together they form a unique fingerprint.

Cite this